Structure of a G48H mutant of HIV-1 protease explains how glycine-48 replacements produce mutants resistant to inhibitor drugs (Q27748828)

1

0 references

X J Zhang

2

0 references

S Foundling

3

0 references

J A Hartsuck

4

0 references

J Tang

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

5

0 references

language of work or name

English

0 references

publication date

22 December 1997

0 references

published in

FEBS Letters

0 references

volume

420

0 references

issue

1

0 references

page(s)

11-6

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901477-4

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901477-4

Ordered accumulation of mutations in HIV protease confers resistance to ritonavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901477-4

In vivo resistance to a human immunodeficiency virus type 1 proteinase inhibitor: mutations, kinetics, and frequencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901477-4

Antiviral properties of Ro 31-8959, an inhibitor of human immunodeficiency virus (HIV) proteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901477-4

L-735,524: the design of a potent and orally bioavailable HIV protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901477-4

ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901477-4

Effect of point mutations on the kinetics and the inhibition of human immunodeficiency virus type 1 protease: relationship to drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901477-4

Human immunodeficiency virus. Mutations in the viral protease that confer resistance to saquinavir increase the dissociation rate constant of the protease-saquinavir complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901477-4

Kinetic properties of saquinavir-resistant mutants of human immunodeficiency virus type 1 protease and their implications in drug resistance in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901477-4

Structural basis of drug resistance for the V82A mutant of HIV-1 proteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901477-4

Three-dimensional Structure of a Mutant HIV-1 Protease Displaying Cross-resistance to All Protease Inhibitors in Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901477-4

Crystal structures of complexes of a peptidic inhibitor with wild-type and two mutant HIV-1 proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901477-4

Improved methods for building protein models in electron density maps and the location of errors in these models

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901477-4

Novel binding mode of highly potent HIV-proteinase inhibitors incorporating the (R)-hydroxyethylamine isostere

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901477-4

Flap opening in HIV-1 protease simulated by 'activated' molecular dynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901477-4

Sequence requirements of the HIV-1 protease flap region determined by saturation mutagenesis and kinetic analysis of flap mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901477-4

Three-dimensional structure of a simian immunodeficiency virus protease/inhibitor complex. Implications for the design of human immunodeficiency virus type 1 and 2 protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901477-4

Database of three-dimensional structures of HIV proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901477-4

A kinetic model for comparing proteolytic processing activity and inhibitor resistance potential of mutant HIV-1 proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901477-4